Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Tachykinin antagonists specifically claimed for asthma by Merck

Feb. 25, 1999

Purinoceptor antagonists claimed by Astra, useful for inflammatory diseases

Feb. 24, 1999

Dura and Spiros update joint development programs

Feb. 24, 1999

Janssen presents selective IL-5 production inhibitors for allergic and inflammatory disorders

Feb. 23, 1999

Serevent now available in Canada as a treatment for chronic obstructive pulmonary disease

Feb. 22, 1999

Structurally novel antiinflammatory/antiallergic agents in the Astra pipeline

Feb. 22, 1999

Potent bradykinin antagonists developed at Fournier

Feb. 19, 1999

FR-167653 compared to dexamethasone in acute lung inflammation

Feb. 18, 1999

PathoGenesis's CF treatment approved in Canada and Argentina

Feb. 17, 1999

S-5920 superior to methylprednisolone in protecting against ARDS

Feb. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....